Craneware forms Alliance with Microsoft

Craneware plc
02 July 2024
 

Craneware plc

("Craneware", "The Craneware Group", the "Company" or the "Group")

Craneware forms Alliance with Microsoft to further transform the business of healthcare

Craneware named a Microsoft Global Partner Solution provider and agrees to joint go-to-market plan for its Trisus offerings

2 July 2024 - Craneware (AIM: CRW.L), the market leader in value cycle solutions for the U.S. healthcare market, is pleased to announce that it has signed agreements with Microsoft in the areas of the Microsoft Azure cloud platform, technical innovation, and healthcare industry collaboration, including joint marketing initiatives. The collaboration will see the delivery of differentiated offerings and increased value to customers through the application of industry leading data analytics, AI, and modern platform technology. As part of the agreement, Craneware's Trisus Platform and select Trisus offerings will be available on the Azure Marketplace. Craneware has also signed a Microsoft Azure Consumption Commitment (MACC) agreement.

 

Strategic Highlights: 

 

·     

Accelerated innovation of The Craneware Group's solutions utilising Microsoft Azure's advanced tools and services

·     

Ease of access for healthcare customers to purchase the Trisus Platform and products via the marketplace, pre-configured and ready to deploy on Microsoft Azure

·     

A proactive go-to-market plan, including joint marketing initiatives

·     

Expanded cloud capabilities through access to additional advanced features of the Microsoft Azure cloud platform

·     

Predictable cloud spending, budget optimisation, and enhanced financial planning, thus driving cost efficiency through the MACC agreement

Craneware teams have begun co-innovation with Microsoft's AI experts to accelerate the application of AI enhancements to existing Trisus offerings and the exploration of new AI-based applications. Craneware's long heritage in the U.S. healthcare industry, as well as nearly 200 million unique patient encounters within its datasets, mean it is uniquely positioned to provide powerful, actionable insights to participants across the healthcare industry. These insights support better operational and strategic decisions, enabling further efficiencies in provider performance so they can focus on serving their communities and healthcare missions, transforming the business of healthcare.

The first of the Trisus applications to be made available on the Microsoft commercial marketplace in July 2024 will be Trisus Chargemaster, Trisus Decision Support, and Trisus Labor Productivity. These offerings, supported by joint go-to-market initiatives and other activities will help expand The Craneware Group's market reach via the Microsoft partner ecosystem.

Keith Neilson, CEO and Co-Founder at The Craneware Group, commented, "We are delighted to strengthen our relationship with Microsoft and their Global Partner Solutions team, with the aim of bringing powerful AI offerings to the U.S. healthcare industry. This agreement deepens our relationship with Microsoft, aligning strategic goals and fostering collaboration on future technology initiatives, marking a milestone in our journey to transform the business of healthcare."

"By combining the power of Microsoft Azure and its AI capabilities with Craneware's innovative healthcare revenue integrity solutions, we're thrilled to be able to support Craneware in not only elevating healthcare providers' operational efficiency and financial performance, but also enhancing the quality of patient care," said Gareth Hall, senior director, Health & Life Sciences, Microsoft. "Together, we can bring advanced AI-powered solutions to market that will help healthcare customers transform their businesses, deliver impactful solutions, and demonstrate the additional power of the Microsoft Cloud for Healthcare." 

 

For further information, please contact:

 


 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO


Craig Preston, CFO




 


Alma Strategic Communications

+44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon

craneware@almastrategic.com



 


Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Benjamin Cryer, Kate Bannatyne




 


Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie


  


Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons


 

 

About Craneware

 

The Craneware Group (AIM:CRW.L), is the market leader in value cycle solutions. For 25 years, we have collaborated with U.S. healthcare providers to optimize revenue integrity, pricing intelligence, decision support, labor productivity, business of pharmacy, and 340B program management.  

 

Customers choose Trisus®, a HITRUST- and SOC2 Type II-certified, SaaS-platform, to achieve operational and financial excellence in pursuit of their healthcare mission - delivering quality care to their communities. The Craneware Group - Transforming the Business of Healthcare.  

 

Learn more at www.thecranewaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Craneware (CRW)
UK 100

Latest directors dealings